OX-118

N/A

Report date: 2025/07/02 11:27:56

Base Information

Drug NameOX-118
Drug Alias NameOX-118
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionAnti-Tumor necrosis factor ligand superfamily member 4
TargetsTumor necrosis factor ligand superfamily member 4
Therapy Area/IndicationsAutoimmune DiseasesImmune System DiseasesRheumatic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOxion Biologics AB
China Registration ClassN/A

Develop Information

Active CompaniesOxion Biologics AB
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesRheumatic Diseases
Inactive IndicationsImmune System Diseases

Other Information

ATC CodeN/A
Related LinksN/A